156 related articles for article (PubMed ID: 33794467)
1. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
MacMillan TE; Cavalcanti RB
Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
[TBL] [Abstract][Full Text] [Related]
3. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin and the risk of hyponatremia: A population-based cohort study.
Fralick M; Schneeweiss S; Wallis CJD; Jung EH; Kesselheim AS
PLoS Med; 2019 Oct; 16(10):e1002930. PubMed ID: 31634354
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyponatremia.
Sterns RH; Hix JK; Silver S
Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):493-8. PubMed ID: 20539224
[TBL] [Abstract][Full Text] [Related]
6. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
8. A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.
Aratani S; Hara M; Nagahama M; Taki F; Futatsuyama M; Tsuruoka S; Komatsu Y
BMC Nephrol; 2017 Oct; 18(1):316. PubMed ID: 29047375
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
MacMillan TE; Tang T; Cavalcanti RB
Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
[TBL] [Abstract][Full Text] [Related]
10. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
[TBL] [Abstract][Full Text] [Related]
11. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
[TBL] [Abstract][Full Text] [Related]
12. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia.
Lim CC; Siow B; Choo JCJ; Chawla M; Chin YM; Kee T; Lee PH; Foo M; Tan CS
Int Urol Nephrol; 2019 Jun; 51(6):995-1004. PubMed ID: 31028561
[TBL] [Abstract][Full Text] [Related]
13. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
Ochiai H; Uenishi E
Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
[TBL] [Abstract][Full Text] [Related]
14. Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?
Tzamaloukas AH; Shapiro JI; Raj DS; Murata GH; Glew RH; Malhotra D
Am J Med Sci; 2014 Nov; 348(5):432-9. PubMed ID: 25247759
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial.
Pakchotanon K; Kanjanasuphak N; Chuasuwan A; Gojaseni P; Chittinandana A
Sci Rep; 2024 Mar; 14(1):7487. PubMed ID: 38553491
[TBL] [Abstract][Full Text] [Related]
16. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis.
Donoghue MB; Latimer ME; Pillsbury HL; Hertzog JH
Arch Pediatr Adolesc Med; 1998 Mar; 152(3):290-2. PubMed ID: 9529469
[TBL] [Abstract][Full Text] [Related]
18. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
Robson WL; Leung AK; Norgaard JP
J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
[TBL] [Abstract][Full Text] [Related]
19. Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis.
Odeh M; Oliven A
J Clin Pharmacol; 2001 May; 41(5):582-4. PubMed ID: 11361055
[TBL] [Abstract][Full Text] [Related]
20. Intranasal desmopressin-induced hyponatremia.
Williford SL; Bernstein SA
Pharmacotherapy; 1996; 16(1):66-74. PubMed ID: 8700794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
